This observation is in line with previous studies showing that reduced circulating BDNF concentrations are associated with neurodegenerative and neuropsychiatric conditions, including Alzheimer’s disease, depression, and schizophrenia, all characterized by impaired synaptic plasticity and neuronal resilience [31,53,54]. Here, BDNF is linked to depressive symptom measurement.